By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

GlobeImmune, Inc. 

1450 Infinite Drive

Louisville  Colorado  80027  U.S.A.
Phone: 303-625-2700 Fax: 303-625-2710


SEARCH JOBS








Company News
GlobeImmune, Inc. (GBIM) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriter's Overallotment Option 7/9/2014 9:05:06 AM
Colorado's GlobeImmune, Inc. (GBIM) Prices IPO At $10 A Share, Below Expectations 7/2/2014 6:07:32 AM
Louisville's GlobeImmune, Inc. Reduces Size Of Proposed IPO 5/22/2014 7:51:38 AM
Pancreatic Cancer Biotech GlobeImmune, Inc. Sets Terms For $35 Million In Second IPO Attempt 4/30/2014 7:03:37 AM
Colorado-Based GlobeImmune, Inc. Gives IPO A Second Shot, Aims For $35 Million 3/18/2014 7:36:16 AM
Biotech GlobeImmune, Inc. Withdraws $60 Million IPO 11/1/2013 7:44:57 AM
GlobeImmune, Inc. Offers IPO Details 9/6/2012 8:26:34 AM
GlobeImmune, Inc. Files Paperwork for $69 Million IPO 7/3/2012 6:21:39 AM
GlobeImmune, Inc.'s GI-4000 in Combination With Gemcitabine Following Surgery Shows Evidence of an Improvement in Survival in a Phase 2b Clinical Trial With Ras Mutation Positive Pancreas Cancer 6/27/2012 9:09:15 AM
GlobeImmune, Inc. Initiates Phase 1 Clinical Trial of GI-6301 in Brachyury Expressing Cancers 2/8/2012 11:43:28 AM
123456
//-->